Treatment of keratoacanthoma with 5% imiquimod cream and review of the previous report

Annals of Dermatology

Volumn 23, Issue 3, 2011, Pages 357-361

  Jeon, Hye Chan ^a   Choi, Mira ^a   Paik, Seung Hwan ^a   Ahn, Chang Ho ^a   Park, Hyun Sun ^a   Cho, Kwang Hyun ^a  

^a Seoul National University   (South Korea)

Author keywords

Imiquimod; Keratoacanthoma

Indexed keywords

EID: 80052084693     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2011.23.3.357     Document Type: Review

References (17)

1. Karaa A, Khachemoune A. Keratoacanthoma: a tumor in search of a classification. Int J Dermatol 2007;46:671-678. (Pubitemid 47046182)
2. Beham A, Regauer S, Soyer HP, Beham-Schmid C. Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma. Adv Anat Pathol 1998;5:269-280.
3. Kwittken J. A histologic chronology of the clinical course of the keratocarcinoma (so-called keratoacanthoma). Mt Sinai J Med 1975;42:127-135.
4. Griffiths RW. Keratoacanthoma observed. Br J Plast Surg 2004;57:485-501. (Pubitemid 39145148)
5. Seifert A, Nasemann T. Keratoacanthoma and its clinical variants. Review of the literature and histopathologic analysis of 90 cases. Hautarzt 1989;40:189-202. (Pubitemid 19110688)
6. Yoshikawa K, Katagata Y, Kondo S. Relative amounts of keratin 1 7 are higher than those of keratin 16 in hair-folliclederived tumors in comparison with nonfollicular epithelial skin tumors. J Invest Dermatol 1995;104:396-400.
7. Schwartz RA. Keratoacanthoma: a clinico-pathologic enigma. Dermatol Surg 2004;30:326-333. (Pubitemid 38313991)
8. Yuge S, Godoy DA, Melo MC, Sousa DS, Soares CT. Keratoacanthoma centrifugum marginatum: response to topical 5-fluorouracil. J Am Acad Dermatol 2006;54(5 Suppl):S218-219.
9. Vergara A, Isarrfa MJ, Domfnguez JD, Gamo R, Rodriguez Peralto JL, Guerra A. Multiple and relapsing keratoacanthomas developing at the edge of the skin grafts site after surgery and after radiotherapy. Dermatol Surg 2007;33:994-996. (Pubitemid 47106746)
10. Annest NM, Van Beek MJ, Arpey CJ, Whitaker DC. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature. J Am Acad Dermatol 2007;56:989-993. (Pubitemid 46720214)
11. Dendorfer M, Oppel T, Wollenberg A, Prinz JC. Topical treatment with imiquimod may induce regression of facial keratoacanthoma. Eur J Dermatol 2003;13:80-82. (Pubitemid 36228516)
12. Bhatia N. Imiquimod as a possible treatment for keratoacanthoma. J Drugs Dermatol 2004;3:71-74.
13. Di Lernia V, Ricci C, Albertini G. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream. J Eur Acad Dermatol Venereol 2004;18:626-629. (Pubitemid 39255764)
14. Kim YJ, Hwang ES, Son SW, Kim IH. Topical treatment with 5% imiquimod for solitary keratoacanthoma. Korean J Dermatol 2004;42:1321-1324. (Pubitemid 39657713)
15. Ko NY, Park JH, Son SW, Kim IH. Treatment of keratoacanthoma with 5% imiquimod cream. Ann Dermatol 2006;18:14-17.
16. Calista D, Morri M. Topical imiquimod for the treatment of keratoacanthomas. Eur J Dermatol 2008;18:590-591.
17. Paternó EJ, Campione E, Diluvio L, Orlandi A, Chimenti S. Imiquimod for restoring local immunity in a renal transplant patient with persistent keratoacanthoma. Dermatol Online J 2008;14:8.